Several preclinical and clinical studies suggested that IL6R inhibitors, such as Tocilizumab, Sarilumab, and Olamkicept, can be effective in some cancer type including ovarian, pancreatic, breast cancer, and B cell chronic lymphocytic leukemia [7]. The gene discussed is IL6R; the disease is B-cell chronic lymphocytic leukemia.